1
|
Kianpour S, Ebrahiminezhad A, Heidari R, Khalvati B, Shahbazi MA, Negahdaripour M, Mohkam M, Aghaei R, Berenjian A, Niknezhad SV, Ghasemi Y. Enterobacter sp. Mediated Synthesis of Biocompatible Nanostructured Iron-Polysaccharide Complexes: a Nutritional Supplement for Iron-Deficiency Anemia. Biol Trace Elem Res 2020; 198:744-755. [PMID: 32157632 DOI: 10.1007/s12011-020-02101-2] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Accepted: 02/27/2020] [Indexed: 01/01/2023]
Abstract
FDA has approved iron oxide nanoparticles (IONs) coated with organic compounds as a safe material with less toxic effects compared with the naked metal ions and nanoparticles. In this study, the biological and physicochemical characteristics of a nanostructured iron-polysaccharide complexes (Nano-IPC) biosynthesized by Enterobacter sp. were evaluated. Furthermore, the serum biochemical parameters, tissue iron level, red blood cell parameters, and organ ferritin of rats were measured for investigating the effect of the Nano-IPCs in comparison with FeSO4 as a supplement for iron deficiency. The biosafety data demonstrated 35% increment of viability in Hep-G2 hepatocarcinoma cell lines when treated with nanoparticles (500 μg/mL) for 24 h. Besides, iron concentration in serum and tissue as well as the expression of ferritin L subunit in animals treated with the Nano-IPCs supplement were meaningfully higher than the FeSO4-supplemented and negative control animals. Moreover, the expression level of ferritin H subunit and biochemical factors remained similar to the negative control animals in the Nano-IPC-supplemented group. These results indicated that Nano-IPCs can be considered as a nontoxic supplement for patients carrying iron-deficiency anemia (IDA).
Collapse
Affiliation(s)
- Sedigheh Kianpour
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 1583, 71345 Karafarin Street, Shiraz, Iran
- Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Alireza Ebrahiminezhad
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Reza Heidari
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Bahman Khalvati
- Medicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
| | - Mohammad-Ali Shahbazi
- Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, Helsinki, Finland
- Department of Pharmaceutical Nanotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, 4513956184, Iran
| | - Manica Negahdaripour
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 1583, 71345 Karafarin Street, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Milad Mohkam
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 1583, 71345 Karafarin Street, Shiraz, Iran
- Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Roghayyeh Aghaei
- Department of Marine Chemistry, Faculty of Marine Science, Chabahar Maritime University, Chabahar, Iran
| | - Aydin Berenjian
- School of Engineering, Faculty of Science and Engineering, University of Waikato, Hamilton, New Zealand
| | - Seyyed Vahid Niknezhad
- Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Younes Ghasemi
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 1583, 71345 Karafarin Street, Shiraz, Iran.
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
| |
Collapse
|
2
|
Kianpour S, Ebrahiminezhad A, Deyhimi M, Negahdaripour M, Raee MJ, Mohkam M, Rezaee H, Irajie C, Berenjian A, Ghasemi Y. Structural characterization of polysaccharide-coated iron oxide nanoparticles produced by Staphylococcus warneri, isolated from a thermal spring. J Basic Microbiol 2019; 59:569-578. [PMID: 30980727 DOI: 10.1002/jobm.201800684] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2018] [Revised: 02/26/2019] [Accepted: 03/02/2019] [Indexed: 02/02/2023]
Abstract
The biocompatible-coated iron oxide nanoparticles (IONs) have attracted a great interest because of their various applications in biological science and medicine. In most cases, the toxic effect of naked iron oxide nanoparticles is completely cleared by adding a biocompatible coating, such as polysaccharides, polyethylene glycol (PEG), or biosynthesis of biocompatible-coated IONs using microorganisms such as bacteria. In the present study, polysaccharide-coated iron oxide nanoparticles were produced by a strain of Staphylococcus warneri isolated from a thermal spring. For identification of the isolated bacterium, 16S rRNA gene sequencing was done. Characterization of the nanoparticles was performed for the first time, using transmission electron microscopy (TEM), dynamic light scattering (DLS), thermogravimetric analysis (TGA), X-ray crystallography (XRD), Fourier-transform infrared (FTIR) spectroscopy, vibrating sample magnetometer (VSM), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Results indicated that the spherical iron oxide nanoparticles were coated by a polysaccharide (13.6%), which provided a large negative charge of -91 mV and very low saturation magnetization of around 0.28 emu/g. The result of MTT assay on MOLT-4 cell lines showed that the percentage of viability was between 95.6% and 68.9% in the 10-100 µM of nanoparticle concentrations with a high IC 50 value, which makes it appropriate for biomedical applications such as cancer therapy.
Collapse
Affiliation(s)
- Sedigheh Kianpour
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Department of Pharmaceutical Biotechnology, Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Alireza Ebrahiminezhad
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.,Department of Pharmaceutical Biotechnology, Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Maryam Deyhimi
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Manica Negahdaripour
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Department of Pharmaceutical Biotechnology, Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mohammad Javad Raee
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Department of Pharmaceutical Biotechnology, Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Milad Mohkam
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Department of Pharmaceutical Biotechnology, Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.,Department of Pharmaceutical Biotechnology, Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Hamideh Rezaee
- Department of Pharmaceutical Biotechnology, Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.,Department of biochemistry and Molecular Biology, Faculty of Science, School of Molecular Sciences, The University of Western Australia, Perth, Western Australia, Australia
| | - Cambyz Irajie
- Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Aydin Berenjian
- Department of Chemical and Biological Engineering, School of Engineering, Faculty of Science and Engineering, University of Waikato, Hamilton, New Zealand
| | - Younes Ghasemi
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.,Department of Pharmaceutical Biotechnology, Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| |
Collapse
|
3
|
Kianpour S, Ebrahiminezhad A, Negahdaripour M, Mohkam M, Mohammadi F, Niknezhad SV, Ghasemi Y. Characterization of biogenic Fe (III)-binding exopolysaccharide nanoparticles produced by Ralstonia sp. SK03. Biotechnol Prog 2018; 34:1167-1176. [PMID: 29882269 DOI: 10.1002/btpr.2660] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2017] [Revised: 05/06/2018] [Indexed: 12/13/2022]
Abstract
A new technological approach to nanoparticle synthesis is using microorganisms, such as bacteria, which have the ability to synthesize nontoxic nanoparticles with high biocompatibility. In addition, bacteria have strict control over size, structure, shape, and dimension of produced nanoparticles. In the present work, Fe (III)-binding exopolysaccharide (Fe-EPS) nanoparticles were biosynthesized by Ralstonia pickettii sp. SK03, a bacterium isolated from a mineral spring. 16S rRNA gene sequencing and biochemical tests were done for identification of the isolated bacterium. For the first time, critical biological and physicochemical properties of this iron oxide nanoparticle were characterized using Fourier Transform Infrared (FTIR) Spectroscopy, Transmission Electron Microscopy (TEM), Vibrating Sample Magnetometer (VSM), Dynamic Light Scattering (DLS), Thermogravimetric analysis (TGA), X-ray crystallography (XRD), Atomic absorption spectroscopy (AAS), and cell viability assays (MTT assay). The characterization results showed that Fe-EPS nanoparticles were composed of spherical ferrihydrite nanoparticles (with a size range of 1.2-2 nm), trapped in a polysaccharide matrix. The TGA analysis demonstrated that Fe-EPS nanoparticles contained ∼25.2% polysaccharide. Therefore, this polysaccharide matrix showed a very low magnetic saturation value (0.25 emu/g) and a large negative charge of -93.8 mV. In addition, treatment of hepatocarcinoma cell line (Hep-G2) with 1-500 µg/mL concentrations of Fe-EPS nanoparticles caused 40% increase in the cell viability, which indicated that the biosynthesized nanoparticles were nontoxic and biocompatible. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 2018 © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 34:1167-1176, 2018.
Collapse
Affiliation(s)
- Sedigheh Kianpour
- Dept. of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.,Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Alireza Ebrahiminezhad
- Dept. of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.,Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
| | - Manica Negahdaripour
- Dept. of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Milad Mohkam
- Dept. of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.,Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Fatemeh Mohammadi
- Dept. of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Seyyed Vahid Niknezhad
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.,Dept. of Chemical Engineering, Faculty of Engineering, Noshirvani University of Technology, Babol, Iran
| | - Younes Ghasemi
- Dept. of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| |
Collapse
|
4
|
Ebrahiminezhad A, Zare M, Kiyanpour S, Berenjian A, Niknezhad SV, Ghasemi Y. Biosynthesis of xanthangum‐coated INPs by using Xanthomonas campestris. IET Nanobiotechnol 2017; 12:254-258. [PMCID: PMC8676424 DOI: 10.1049/iet-nbt.2017.0199] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2017] [Revised: 10/26/2017] [Accepted: 11/04/2017] [Indexed: 11/25/2023] Open
Abstract
Synthesis of iron nanoparticles (INPs) with a biocompatible coating usually is a multistep process which requires harsh, special and protected reaction conditions. In the current experiment, the authors used Xanthomonas campestris cells to develop a facile method for fabrication of biocompatible INPs. Bacterial cells were supplied with ferric citrate as an iron precursor. Transmission electron microscopy micrographs exhibited that xanthan gum‐coated INPs are synthesised and deposited on the surface of X. campestris cells and produced nanoparticles were 20–80 nm in diameter with 41.7 nm mean particle size. Xanthan gum coating with about 7 nm thickness formed a clear hollow around each nanoparticle. According to thermogravimetric analysis, the coating was about 13.4% of the total INPs weight. Prepared particles had a zeta potential of −114 mv which is an ideal surface charge to make particles colloidally stable in aqueous matrixes. Xanthan gum‐coated INPs were non‐crystalline with low saturation magnetisation value of about 0.26 emu/g.
Collapse
Affiliation(s)
- Alireza Ebrahiminezhad
- Department of Medical BiotechnologySchool of Medicine, and Noncommunicable Diseases Research CentreFasa University of Medical SciencesFasaIran
- Department of Medical NanotechnologySchool of Advanced Medical Sciences and TechnologiesShiraz University of Medical SciencesShirazIran
- Department of Pharmaceutical BiotechnologySchool of Pharmacy and Pharmaceutical Sciences Research CentreShiraz University of Medical SciencesShirazIran
| | - Marziyeh Zare
- Department of Medical BiotechnologySchool of Medicine, and Noncommunicable Diseases Research CentreFasa University of Medical SciencesFasaIran
| | - Sedigheh Kiyanpour
- Department of Pharmaceutical BiotechnologySchool of Pharmacy and Pharmaceutical Sciences Research CentreShiraz University of Medical SciencesShirazIran
| | - Aydin Berenjian
- School of EngineeringFaculty of Science and EngineeringThe University of WaikatoHamiltonNew Zealand
| | - Seyyed Vahid Niknezhad
- Department of Pharmaceutical BiotechnologySchool of Pharmacy and Pharmaceutical Sciences Research CentreShiraz University of Medical SciencesShirazIran
| | - Younes Ghasemi
- Department of Medical NanotechnologySchool of Advanced Medical Sciences and TechnologiesShiraz University of Medical SciencesShirazIran
- Department of Pharmaceutical BiotechnologySchool of Pharmacy and Pharmaceutical Sciences Research CentreShiraz University of Medical SciencesShirazIran
| |
Collapse
|
5
|
Aarti C, Khusro A, Agastian P. Goat dung as a feedstock for hyper-production of amylase from Glutamicibacter arilaitensis strain ALA4. BIORESOUR BIOPROCESS 2017. [DOI: 10.1186/s40643-017-0174-4] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
|
6
|
A diketopiperazine factor from Rheinheimera aquimaris QSI02 exhibits anti-quorum sensing activity. Sci Rep 2016; 6:39637. [PMID: 28000767 PMCID: PMC5175134 DOI: 10.1038/srep39637] [Citation(s) in RCA: 43] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Accepted: 11/24/2016] [Indexed: 02/03/2023] Open
Abstract
An ethyl acetate (EtOAc) extract isolated from the marine bacterium, Rheinheimera aquimaris QSI02, was found to exhibit anti-quorum sensing (anti-QS) activity. A subsequent bioassay-guided isolation protocol led to the detection of an active diketopiperazine factor, cyclo(Trp-Ser). Biosensor assay data showed that the minimum inhibitory concentration (MIC) of cyclo(Trp-Ser) ranged from 3.2 mg/ml to 6.4 mg/m for several microorganisms, including Escherichia coli, Chromobacterium violaceum CV026, Pseudomonas aeruginosa PA01, Staphylococcus aureus, and Candida albicans. Additionally, sub-MICs of cyclo(Trp-Ser) decreased the QS-regulated violacein production in C. violaceum CV026 by 67%. Furthermore, cyclo(Trp-Ser) can decrease QS-regulated pyocyanin production, elastase activity and biofilm formation in P. aeruginosa PA01 by 65%, 40% and 59.9%, respectively. Molecular docking results revealed that cyclo(Trp-Ser) binds to CviR receptor more rigidly than C6HSL with lower docking energy −8.68 kcal/mol, while with higher binding energy of −8.40 kcal/mol than 3-oxo-C12HSL in LasR receptor. Molecular dynamics simulation suggested that cyclo(Trp-Ser) is more easy to bind to CviR receptor than natural signaling molecule, but opposite in LasR receptor. These results suggest that cyclo(Trp-Ser) can be used as a potential inhibitor to control QS systems of C. violaceum and P. aeruginosa and provide increased the understanding of molecular mechanism that influences QS-regulated behaviors.
Collapse
|
7
|
Kianpour S, Ebrahiminezhad A, Mohkam M, Tamaddon AM, Dehshahri A, Heidari R, Ghasemi Y. Physicochemical and biological characteristics of the nanostructured polysaccharide-iron hydrogel produced by microorganism Klebsiella oxytoca. J Basic Microbiol 2016; 57:132-140. [PMID: 27859419 DOI: 10.1002/jobm.201600417] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2016] [Accepted: 10/07/2016] [Indexed: 02/03/2023]
Abstract
There is an increasing interest in the nanostructured polysaccharide-iron hydrogel produced by Klebsiella oxytoca. Critical physicochemical and biological characteristics of these nanostructures should be revealed for biomedical applications. Accordingly, an iron reducing strain K. oxytoca, which synthesizes biogenic polysaccharide-iron hydrogel nanoparticles, known as Fe (III)-exopolysaccharide (Fe-EPS) was isolated from a mineral spring. For microbiological identification purpose 16S rRNA sequence analysis and different morphological, physiological, and biochemical characteristics of the isolate were studied. Critical physicochemical and biological characteristics of the produced Fe-EPS were evaluated using transmission electron microscopy (TEM), Fourier transform infrared (FTIR) spectroscopy, X-ray crystallography (XRD), vibrating sample magnetometer (VSM). In addition, for the first time, Fe-EPS which synthesized by K. oxytoca was evaluated by dynamic light scattering (DLS), thermo gravimetric analysis (TGA), and cytotoxicity assay. TEM micrographs showed that the biogenic Fe-EPS is composed of ultra-small (about 1.8 nm) iron oxide nanoparticles (IONs) which are trapped in a polysaccharide matrix. The matrix was about 17% (w/w) of Fe-EPS total weight and provided a large negative charge of -71 mV. Interestingly, Fe-EPS showed a growth promotion effect on hepatocarcinoma cell line (Hep-G2) and 36% increase in the percentage of viability was observed by 24 h exposure to 500 μg ml-1 Fe-EPS.
Collapse
Affiliation(s)
- Sedigheh Kianpour
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Alireza Ebrahiminezhad
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.,Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.,Department of Medical Biotechnology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
| | - Milad Mohkam
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Ali Mohammad Tamaddon
- Center for Nanotechnology in Drug Delivery and Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Shiraz University of Medical Science, Shiraz, Iran
| | - Ali Dehshahri
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Reza Heidari
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Younes Ghasemi
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.,Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| |
Collapse
|
8
|
Sen SK, Raut S, Satpathy S, Rout PR, Bandyopadhyay B, Das Mohapatra PK. Characterizing novel thermophilic amylase producing bacteria from taptapani hot spring, odisha, India. Jundishapur J Microbiol 2014; 7:e11800. [PMID: 25741425 PMCID: PMC4335550 DOI: 10.5812/jjm.11800] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2013] [Revised: 09/08/2013] [Accepted: 09/25/2013] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND Amylases play a vital role in biotechnological studies and rank an important position in the world enzyme market (25% to 33%). Bioprocess method of amylase production is more effective than the other sources, since the technique is easy, cost effective, fast, and the enzymes of required properties can be procured. OBJECTIVES The current study aimed to report the characteristics of novel amylase producing bacterial strains isolated from Taptapani hot spring, Odisha, India. MATERIALS AND METHODS Bacterial strains were isolated by dilution plating method from the water samples collected from Taptapani Hot Spring, Odisha and screened for amylase production through starch hydrolysis. The bacterial isolates were identified morphologically, biochemically, and finally by 16S rDNA profiling. RESULTS Based on the morphological, physiological, biochemical characteristics and the molecular characterization, the isolates SS1, SS2, and SS3 were identified as Bacillus barbaricus, Aeromonas veroni, and Stenotrophomonas maltophilia, respectively. The approximate molecular weight of enzymes from SS1, SS2, and SS3 strains were 19 kDa, 56 kDa and 49 kDa, respectively. CONCLUSIONS The current report isolates, characterizes, and demonstrates the novel heat-adapted amylase-producing bacteria SS1, SS2 and SS3 from Taptapani hot spring, indicating its potentiality and stability under acidic conditions.
Collapse
Affiliation(s)
- Sudip Kumar Sen
- Department of Biotechnology, Gandhi Institute of Engineering and Technology, Gunupur, Odisha, India
| | - Sangeeta Raut
- Department of Biotechnology, Gandhi Institute of Engineering and Technology, Gunupur, Odisha, India
| | - Soumya Satpathy
- Department of Biotechnology, Gandhi Institute of Engineering and Technology, Gunupur, Odisha, India
| | - Prangya Ranjan Rout
- Department of Biotechnology, National Institute of Technology, Warangal, Andhra Pradesh, India
| | - Bidyut Bandyopadhyay
- Department of Biotechnology, Oriental Institute of Science and Technology, Midnapore, West Bengal, India
| | | |
Collapse
|
9
|
Mageswari A, Subramanian P, Chandrasekaran S, Sivashanmugam K, Babu S, Gothandam K. Optimization and immobilization of amylase obtained from halotolerant bacteria isolated from solar salterns. JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY 2012. [DOI: 10.1016/j.jgeb.2012.09.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
10
|
Ghasemi Y, Rasoul-Amini S, Kazemi A, Zarrini G, Morowvat MH, Kargar M. Isolation and characterization of some moderately halophilic bacteria with lipase activity. Microbiology (Reading) 2011. [DOI: 10.1134/s0026261711040060] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
11
|
Nwagu T, Okolo B. Growth Profile and Amylolytic Activity of a Thermophilic Fungus
Aspergillus fumigatus Isolated from Soil. ACTA ACUST UNITED AC 2010. [DOI: 10.3923/ajbkr.2011.46.57] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|